Fresenius Medical Care AG (FMS) Receivables Refunds (2016 - 2025)
Fresenius Medical Care AG (FMS) has 6 years of Receivables Refunds data on record, last reported at $152.4 million in Q4 2024.
- For Q4 2024, Receivables Refunds changed N/A year-over-year to $152.4 million; the TTM value through Dec 2024 reached $152.4 million, changed N/A, while the annual FY2024 figure was $154.3 million, N/A changed from the prior year.
- Receivables Refunds reached $152.4 million in Q4 2024 per FMS's latest filing, up from $125.4 million in the prior quarter.
- Across five years, Receivables Refunds topped out at $162.2 million in Q4 2020 and bottomed at $125.4 million in Q4 2021.
- Average Receivables Refunds over 3 years is $146.6 million, with a median of $152.4 million recorded in 2024.
- The widest YoY moves for Receivables Refunds: up 22.71% in 2021, down 22.71% in 2021.
- A 3-year view of Receivables Refunds shows it stood at $162.2 million in 2020, then decreased by 22.71% to $125.4 million in 2021, then rose by 21.53% to $152.4 million in 2024.
- Per Business Quant database, its latest 3 readings for Receivables Refunds were $152.4 million in Q4 2024, $125.4 million in Q4 2021, and $162.2 million in Q4 2020.